Evidence map›Paper›PMID 39796170›Full record

ArticleInternational journal of molecular sciences2025

Mechanism of P-Hydroxy Benzyl Alcohol Against Cerebral Ischemia Based on Metabonomics Analysis.

Tian Xiao, Xingling Yu, Jie Tao, Jiaoyang Tan, Zhourong Zhao, Chao Zhang, Xiaohua Duan

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Tian XiaoYunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.ORCID 0009-0000-3333-0063
Xingling YuYunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Jie TaoYunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Jiaoyang TanYunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Zhourong ZhaoYunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Chao ZhangYunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Xiaohua DuanYunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.

Funding

High-level Talents Projects of Yunnan University of Chinese Medicine-Fifth Level Talents 2023-05-007National Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project 'Dai Medicine' Zyyzdxk-2023193National Natural Science Foundation of China 81960733Xingdian Talent Support Program - Special for Young Talent XDYC-QNRC-2022-0284
6 · The paper itself

Abstract

Stroke is the leading cause of death and disability worldwide, with ischemic stroke accounting for the majority of these. HBA is the active ingredient in

Indexed as

Benzyl AlcoholsBrain IschemiaMetabolomicsNeuroprotective AgentsAnimalsDisease Models, AnimalMaleMetabolomeMitochondriaNeuronsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRatsRats, Sprague-DawleySignal TransductionSirtuin 14-hydroxybenzyl alcoholBenzyl AlcoholsNeuroprotective AgentsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSirtuin 1cerebral ischemiacognitive dysfunctionmetabonomicsmitochondrial dysfunctionp-hydroxybenzyl alcohol

Identifiers

PMID39796170
PMCPMC11719616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.